Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SABER .035 PTA Dilatation Catheter

K-Number: K201333 · 2020-09-11

Decision Date2020-09-11
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

SABER .035 PTA Dilatation Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Cordis Corporation. It received FDA 510(k) clearance on 2020-09-11 under 510(k) number K201333. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SABER .035 PTA Dilatation Catheter?

SABER .035 PTA Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2020-09-11. The listed applicant is Cordis Corporation. The 510(k) number is K201333.

When did SABER .035 PTA Dilatation Catheter receive FDA 510(k) clearance?

SABER .035 PTA Dilatation Catheter received FDA 510(k) clearance on 2020-09-11, under 510(k) number K201333.

Who is the listed applicant for SABER .035 PTA Dilatation Catheter?

The FDA 510(k) record lists Cordis Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SABER .035 PTA Dilatation Catheter?

The FDA product code for SABER .035 PTA Dilatation Catheter is LIT.

Other records listing Cordis Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 8 devices →

Related Devices (Code: LIT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.